Back to News
Market Impact: 0.22

This Insurance Stock Has Quietly Crushed the S&P 500 Over 10 Years

PGRNVDAINTCNFLX
Corporate EarningsCompany FundamentalsCapital Returns (Dividends / Buybacks)Technology & InnovationArtificial IntelligenceManagement & GovernanceAnalyst Insights

Progressive posted very strong 2025 results, with its combined ratio below 90% versus a management target below 96%, EPS rising from $14.40 to $19.23, and a $13.50 per-share variable dividend paid in January. The article argues the stock looks fairly valued at 10x earnings and highlights Progressive's use of long-running data and AI/machine learning to support underwriting. Overall, this is a favorable long-term view of the company, though the piece is primarily commentary rather than a new corporate announcement.

Analysis

The market is effectively paying for Progressive as a high-quality compounder rather than a cyclical insurer, which is why valuation appears rich on book but restrained on earnings. The key second-order issue is that a sub-90 combined ratio is likely peak-ish; if loss severity, repair inflation, or weather volatility normalize, the underwriting margin can compress faster than the market expects, and the “cheap” P/E can re-rate upward in a hurry. In other words, the current multiple is less a bargain than a statement that investors believe underwriting discipline is structurally durable. The real competitive edge is not just data volume, but the feedback loop between pricing, claims handling, and customer acquisition. AI should help the largest incumbents widen that loop by lowering acquisition costs and improving risk segmentation, but it also reduces barriers for well-capitalized peers to mimic best practices over a 2-4 year horizon. That suggests the moat is more about execution speed and distribution than technology itself; the upside from AI is likely incremental, while the downside from commoditized pricing is more material if the market hardens less than anticipated. For capital returns, the variable payout is a tell: management is signaling confidence, but it also increases the stock’s beta to underwriting swings. If investors are chasing the dividend as a proxy for quality, the trade is vulnerable to a simple earnings normalization narrative rather than a catastrophic event. The most attractive opportunity may be relative value: if Progressive remains best-in-class, the stock should hold its premium, but if the cycle cools, there is more upside in cheaper insurers with less perfection embedded in expectations.